FDA Approves Lucentis for Diabetic Eye Disorder

The U.S. Food and Drug Administration on Friday recommended wider approval of Roche Holding eye drug, Lucentis. An estimated 75,000 new cases of diabetic macular edema develop each year in the U.S.

Read more

Posted in Drugs